🔎 Trials Near Me

መነሻ › ሂድራዴኒቲስ ሴፕራቲቫ › Texas

በTexas ለሂድራዴኒቲስ ሴፕራቲቫ የሚደረጉ ክሊኒካዊ ጥናቶች

ለሂድራዴኒቲስ ሴፕራቲቫ የሚደረጉ 8 ጥናቶች በTexas ባሉ ቦታዎች ተሳታፊዎችን እየፈለጉ ነው።

በTexas ውስጥ ያሉ ከተሞች

Official study text (English)

An Extension Study to Assess Safety and Efficacy of Remibrutinib in Participants With Moderate to Severe HS

  • Center for Clinical Studies-Lee, Webster
ተሳታዮችን በመፈለግ ላይደረጃ 3
እድሜ ከ18 እስከ 100 · ሁሉም ጾታዎች · የተሻሻለው በ28 ሴፕቴ 2026 · NCT07665437

ORKA-002 Versus Placebo in Participants With Moderate-to-Severe Hidradenitis Suppurativa

  • Oruka Therapeutics Investigative Site, Dallas
  • Oruka Therapeutics Investigative Site, Missouri City
  • Oruka Therapeutics Investigative Site, San Antonio
ተሳታዮችን በመፈለግ ላይደረጃ 2
እድሜ ከ18 እስከ 79 · ሁሉም ጾታዎች · የተሻሻለው በ24 ሴፕቴ 2026 · NCT07783542

A Study to Investigate Efficacy and Safety With SAR445399 in Adult Participants With Moderate to Severe Hidradenitis Suppurativa

  • Elligo Health Research/The Woodlands Dermatology Associates- Site Number : 8400020, The Woodlands
ተሳታዮችን በመፈለግ ላይደረጃ 2
እድሜ 18 እና ከዚያ በላይ · ሁሉም ጾታዎች · የተሻሻለው በ22 ሴፕቴ 2026 · NCT07225569

Rollover Study for Participants Previously Enrolled in Clinical Trials of Povorcitinib

  • Investigative Site US021, Bellaire
  • Investigative Site US078, Dallas
  • Investigative Site US010, Dallas
  • እና 3 ተጨማሪ
ተሳታዮችን በመፈለግ ላይደረጃ 3
እድሜ 18 እና ከዚያ በላይ · ሁሉም ጾታዎች · የተሻሻለው በ15 ሴፕቴ 2026 · NCT06855498

Brivekimig for the Treatment of Moderate to Severe Hidradenitis Suppurativa

  • UT Southwestern Medical Center, Department of Dermatology- Site Number : 8400022, Dallas
ተሳታዮችን በመፈለግ ላይደረጃ 2
እድሜ 18 እና ከዚያ በላይ · ሁሉም ጾታዎች · የተሻሻለው በ20 ኦገስ 2026 · NCT07170917

Pharmacokinetics, Safety, and Efficacy of Povorcitinib in Adolescent Participants With Moderate to Severe Hidradenitis Suppurativa

  • Bellaire Dermatology Associates Bda, Bellaire
  • Texas Dermatology Research Center, Dallas
  • 3A Research Llc West Location, El Paso
ተሳታዮችን በመፈለግ ላይደረጃ 2
እድሜ ከ12 እስከ 17 · ሁሉም ጾታዎች · የተሻሻለው በ6 ኦገስ 2026 · NCT07213973

A Long-Term Follow-Up Observational Study to Evaluate Safety in Subjects Who Have Received a Gene-Modified Regulatory T Cell (Treg) Therapeutic

  • The University of Texas MD Anderson Cancer Center, Houston
ተሳታዮችን በመፈለግ ላይየመመልከት ጥናት
እድሜ ከ18 እስከ 71 · ሁሉም ጾታዎች · የተሻሻለው በ16 ኤፕሪ 2026 · NCT07123038

A Study of Zasocitinib in Adults With Hidradenitis Suppurativa

  • Arlington Research Center, Inc., Arlington
  • Texas Dermatology Research Center, Dallas
ተሳታዮችን በመፈለግ ላይደረጃ 2
እድሜ 18 እና ከዚያ በላይ · ሁሉም ጾታዎች · የተሻሻለው በ6 ማርች 2026 · NCT07244263

ከ ClinicalTrials.gov የተገኘ መረጃ፣ በ5 ኦክቶ 2026 የተሰብሰቡ። እያንዳንዱ ጥናት የራሱን ቅድመ ሁኔታ ይወስናል፤ የጥናት ቡድኑ ማን መሳተፍ እንደሚችል ይወስናል።